Polypeptide-polymer conjugate with improved wash performance

A technology of washing performance and conjugates, which can be used in organic washing compositions, detergent compositions, detergent compounding agents, etc., and can solve the problems of reducing immune response and difficult to identify polypeptides, etc.

Inactive Publication Date: 2001-10-03
NOVO NORDISK AS
52 Cites 9 Cited by

AI-Extracted Technical Summary

Problems solved by technology

When this technique is used, it is difficult for the immune system to recognize the epitopes on the...
View more

Method used

[0044] By proper choice of polymer and molecular structure, better coverage, and more ideally shielding, of epitopes on the surface of the polypeptide can...
View more

Abstract

The present invention relates to a polypeptide-polymer conjugate having coupled one or more polymers covalently to the parent polypeptide, wherein the polymers is homo-polymers, graft, block, alternate, or ramdom co-polymers. The invention also relates to industrial compositions and products comprising a conjugate of the invention and to the use of said conjugate for improving the wash performance of industrial composition and products such as detergent compositions.

Application Domain

Organic detergent compounding agentsEnzyme stabilisation

Technology Topic

Copolymer

Examples

  • Experimental program(24)
  • Effect test(1)

Example Embodiment

[0291] Example 1
[0292] Use N-succinimide carbonate to activate poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) 1.900 (50wt% ethyl
[0293] Diol)
[0294] Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) 1.900 (50 wt% ethylene glycol) (from ALDRICH) was dissolved in toluene (5 ml/g polymer). About 20% is distilled off under normal pressure to azeotropically dry the reactants. The solution was cooled to 20°C and phosgene (1.93M, 7mol/mol polymer) in toluene was added. Then, the mixture was stirred at room temperature overnight. The solvent and excess phosgene were removed in vacuo to obtain an oily intermediate bis(chloroformate).
[0295] Toluene (anhydrous 4ml/g polymer) was added to dissolve the oil again. N-hydroxysuccinimide (NHS) (2.4 mol/mol polymer) was added, and the mixture was cooled in an ice bath. Then triethylamine (2.2mol/mol polymer) was added dropwise at 0°C. The precipitation of triethylamine hydrochloride (Et 3 N. HCl). The mixture was stirred overnight at room temperature. Filter the mixture with a glass filter (G5) to remove Et 3 N.HCl. The filtrate was evaporated to dryness under reduced pressure to obtain 97% (mol/mol) oil. NMR indicated that more than 90% was activated, and there was less than 8o/o (mol/mol) of unbound NHS. Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) 1.900 bis(succinimide carbonate) (50wt% ethylene glycol) 1H-NMR (400MHz) (CDCl 3 )δ:1.15bs(I=330, in the -CH of PPG 3 ), 2.69s (I=1.7 unreacted NHS), 2.83s (I=41, succinimide), 3.41m (I=110, CH-CH in PPG 2 ), 3.55m (I=220, CH-CH in PPG 2 ), 3.61m (I=440 main peak), 4.46t (I=19, CH in PEG 2 -O-CO-).

Example Embodiment

[0296] Example 2
[0297] Activate with N-succinimide carbonate
[0298] Poly(ethylene glycol)-co-(propylene glycol)-monobutyl ether 970 (about 50wt% ethylene glycol)
[0299] Poly(ethylene glycol)-co-(propylene glycol) monobutyl ether 970 (approximately 50 wt% ethylene glycol) (from ALDRICH) was dissolved in toluene (4 ml/g polymer). Under normal pressure, about 25% was removed by distillation to azeotropically dry the reactants. The solution was cooled to 0°C and phosgene (1.93M, 5mol/mol polymer) in toluene was added. Then, the mixture was stirred at room temperature for 21 hours. The solvent and excess phosgene were removed in vacuo to obtain an oily intermediate chloroformate.
[0300] Toluene (anhydrous 2ml/g polymer) was added to dissolve the oil again. At room temperature, N-hydroxysuccinimide (NHS) (1.2mol/mol polymer) was added, and then triethylamine (1.1mol/mol polymer) was added dropwise at 0°C. The precipitation of triethylamine hydrochloride (Et 3 N. HCl). The mixture was stirred overnight at room temperature. Use a porous glass filter (G5) to filter the mixture to remove insoluble Et 3 N.HCl. The filtrate was evaporated to dryness under reduced pressure to obtain 89% (mol/mol) oil. NMR indicated >72% activation and <50/0 (mol/mol) unbound NHS. 1 H-NMR (400MHz, CDCl 3 )δ:0.91t(I=1000-CH 3 Butyl), 1.15bs (I=8744, -CH in propylene glycol 3 ), 1.39m(I=1320 CH 3 -CH 2 -CH 2 -Butyl), 1.55m (I=656-CH 2 -O-butyl), 2.68s (I=60.8 unreacted NHS), 2.83 s (I=963.2, succinimide), 3.40m (I=3059, CH-CH in propylene glycol 2 ), 3.55m (I=2678, CH-CH in propylene glycol 2 ), 3.61m (I=1764 main peak, -CH in ethylene glycol 2 -CH 2 -), 4.46m(CH 2 -O-CO-).

Example Embodiment

[0301] Example 3
[0302] Activate mPEG 350 with N-succinimide carbonate
[0303] The mPEG 350 was suspended in toluene (4 ml/g mPEG), and about 20% was distilled off under normal pressure to azeotropically dry the reactant. When the solution was cooled to 20°C, phosgene (1.93M 1.5mol/mol mPEG) in toluene was added, and the mixture was stirred overnight at room temperature. The mixture was evaporated under reduced pressure, and the obtained intermediate chloroformate was oily.
[0304] After evaporation, dichloromethane and toluene (1:2, anhydrous 4ml/g mPEG) were added to redissolve the colorless oil. Add N-hydroxysuccinimide (NHS) (1.5mol/mol mPEG) in a solid form, and then add triethylamine (1.1mol/mol mPEG) at 0°C. Triethylamine hydrochloride (Et 3 N.HCl) precipitated immediately. The mixture was stirred overnight at room temperature. Filter the mixture with a porous glass filter (G5) to remove Et 3 N.HCl. The filtrate was evaporated to dryness under reduced pressure to obtain 98% (mol/mol) oil. NMR shows that 85-95% is activated and less than 10o/o (mol/mol) HNEt 3 Cl. mPEG 350 Succinimide Carbonate (CDCl 3 )of 1 H-NMR(400MHz)(CDCl 3 )δ is: 1.42t (I=1.4, HNEt 3 CH in Cl 3 ), 2.68s (I=3.4 unreacted NHS), 2.84s (I=6.2 succinimide), 3.10dq (I=1.0, HNEt 3 CH in Cl 2 ), 3.38s (I=5.8, CH in OMe 3 ), 3.64bs (I=50 main peak), 4.47t (I=3.0, CH in PEG 2 ).

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products